News
-
-
-
PRESS RELEASE
Kintara Therapeutics and TuHURA Biosciences Provide Update on Recent Corporate and Clinical Advancements and Outline Near Term Milestones
Kintara Therapeutics, Inc. and TuHURA Biosciences, Inc. provide overview of recent corporate and clinical advancements, with upcoming milestones including merger closing and clinical trial commencement -
-
-
-
PRESS RELEASE
Catheter Precision, Inc. (NYSE American: VTAK) Reports Preliminary Unaudited Revenue for the Second Quarter and Six Months Ended June 30, 2024
Catheter Precision, Inc. reports 15% quarter-over-quarter growth with initial sales of LockeT recorded, generating total revenue of $94,840 for Q2 ending June 30, 2024 -
-
-
PRESS RELEASE
Pentixapharm Announces Expansion of Supervisory Board with the Appointment of Distinguished Endocrinologist Marcus Quinkler
Pentixapharm AG appoints distinguished endocrinologist Marcus Quinkler to its Supervisory Board. Quinkler's expertise in primary aldosteronism aligns with the company's focus on innovative radiopharmaceuticals